PHR stock

Is Phreesia Inc (PHR) overvalued? · rev $419.8M

Phreesia Inc (PHR) is a health information services company listed on US.

This page asks whether Phreesia Inc (PHR) looks expensive on cached numbers — not a short thesis.

Latest reported PHR revenue for 2025-01-31 was $419.8M. Net income was -$58.5M. Revenue was up 17.8% from 2024-01-31 to 2025-01-31. PHR currently screens at market cap $1.70B.

PHR currently screens at market cap $1.70B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next PHR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the PHR stock page for the full model, not this heading.

Not investment advice.

Full PHR analysis